---
title: "Multiple sclerosis: Symptoms & Treatment | HealthAnswers"
description: "Multiple sclerosis (MS) — symptoms, relapsing and progressive types, diagnosis with MRI, and NHS disease-modifying treatments."
url: https://healthanswers.co.uk/conditions/multiple-sclerosis/
robots: noindex
---

# Multiple sclerosis: Symptoms & Treatment | HealthAnswers

Health A–Z

Multiple sclerosis (MS) — symptoms, relapsing and progressive types, diagnosis with MRI, and NHS disease-modifying treatments.

Written by HealthAnswers editorial team Medically reviewed by [HealthAnswers UK doctor review panel](https://healthanswers.co.uk/our-doctors/) Reviewed 3 July 2026

## Quick answer

What is multiple sclerosis? Multiple sclerosis is an autoimmune condition where the immune system attacks the myelin coating of nerves in the brain and spinal cord — causing vision problems, numbness, weakness, balance issues, and fatigue in episodes or progressively. Most common neurological disease in young adults — diagnosis typically 20s to 40s. MRI and neurology assessment confirm. Disease-modifying drugs reduce relapses — no cure yet but outcomes improving. See a GP urgently for sudden vision loss in one eye or new neurological symptoms lasting over 24 hours.

## Who is this page for?

This page is for people in the UK who want a plain-English overview of Multiple sclerosis, including when to seek help and what NHS care usually involves. It explains general information, not what is wrong with you personally.

## Who should skip this page?

Skip this page if you need a diagnosis, a prescription, or emergency care. It cannot replace a GP, pharmacist, NHS 111 or 999. If you are in immediate danger, call 999; for urgent advice that is not life-threatening, call 111 in England, Scotland or Wales, or use your GP out-of-hours service in Northern Ireland.

On this page 5 sections

## Key facts about multiple sclerosis

- MS affects about 130,000 people in the UK — women twice as often as men.
- Relapsing-remitting MS is most common — attacks then partial recovery; primary progressive MS worsens steadily from start.
- Optic neuritis — painful vision loss one eye — common first presentation needing urgent neurology.
- Disease-modifying therapies (DMTs) — ocrelizumab, fingolimod, dimethyl fumarate etc. — reduce relapse rate and disability accumulation.
- Heat often worsens symptoms temporarily (Uhthoff phenomenon) — not new relapse.

## Multiple sclerosis — immune attack on myelin

**Multiple sclerosis (MS)** is **chronic autoimmune demyelination** of **central nervous system** (brain + spinal cord) — **disrupted nerve conduction** → **variable neurological symptoms**.

**Most common disabling neurological disease of young adults** — **UK ~130,000**.

**Peak onset 20s–40s** — **not childhood rare**, **diagnosis later life possible**.

## How MS presents

**Relapsing-remitting pattern:**

- new symptoms over days

- plateau then partial recovery over weeks–months

- attacks separated in time , ** lesions separated in space**

**Common symptoms:**

- optic neuritis — painful monocular vision loss

- sensory — numbness, pins and needles, band-like torso

- motor — weakness, spasticity

- coordination — ataxia, tremor

- brainstem — diplopia , facial weakness

- fatigue — most disabling symptom many

- bladder/bowel — urgency, retention

- cognitive — processing speed

**Progressive forms:**

- SPMS — gradual decline after RRMS

- PPMS — progression from onset — 10–15%

## Diagnosis

**McDonald criteria** — **MRI + clinical**

**MRI brain/spine:**

- periventricular , juxtacortical , infratentorial , spinal T2/FLAIR lesions

- ** Dawson fingers**

- gadolinium enhancement — active inflammation

**LP** — **oligoclonal bands** — **supportive**

**Exclude mimics:**

- NMOSD — aquaporin-4 antibody

- MOGAD

- SLE , Sjögren , sarcoid

- vitamin B12 deficiency

## Treatment

### Relapse

**High-dose IV methylprednisolone** — **3–5 days** — **speeds recovery**, **doesn’t alter long-term disability**

### Disease-modifying therapies (DMTs)

**Reduce relapse rate, MRI activity, disability progression:**

| Efficacy tier | Examples |
| --- | --- |
| Moderate | dimethyl fumarate , teriflunomide , fingolimod |
| High | ocrelizumab , natalizumab , alemtuzumab , cladribine |

**Choice** — **activity**, **prognosis**, **family planning**, **JCV status** (PML risk with natalizumab)

### PPMS

**Ocrelizumab** — **only licensed DMT** with PPMS evidence

### Symptoms

- fatigue — exercise , modafinil selected

- spasticity — baclofen

- neuropathic pain — gabapentin

- bladder — oxybutynin , intermittent self-catheterisation

## Living with MS

**MS Society** — **support**, **benefits advice**

**Heat sensitivity** — **Uhthoff** — **cooling strategies**

**Vitamin D** — **maintain sufficiency**

**Smoking cessation** — **accelerates progression**

**Pregnancy** — **often reduced relapse third trimester**, **rebound postpartum** — **plan with neurologist**

MS is **unpredictable not untreatable** — **early neurology**, **DMT**, **symptom management** preserve **life trajectory**.

## ! When to see a GP about multiple sclerosis

See a GP urgently for new double vision, painful vision loss, facial numbness, limb weakness, balance problems, or bladder dysfunction lasting over 24 hours — neurology referral. Phone 999 if sudden severe weakness, inability to walk when previously able, or symptoms suggest stroke — MS and stroke can overlap in presentation. MS Trust and neurologist coordinate long-term care.

## Common questions about multiple sclerosis

What are the first signs of MS? Optic neuritis — blurred or painful vision one eye; numbness or tingling limbs or face; weakness; balance problems; Lhermitte sign — electric shock down spine on neck flexion; fatigue; bladder urgency. Symptoms often develop over days, last weeks, then improve partially — disseminated in time and space. What causes multiple sclerosis? Autoimmune demyelination — exact trigger unknown — combination of genetic susceptibility and environmental factors (low vitamin D, EBV infection, smoking). Not contagious. More common further from equator — latitude gradient in incidence. Is there a cure for MS? No cure currently — disease-modifying treatments reduce relapses and slow progression especially relapsing forms. Stem cell transplantation (HSCT) for highly active MS in specialist centres. Symptomatic treatments — fatigue management, spasticity drugs, bladder care. Research active globally. What is the difference between relapsing and progressive MS? Relapsing-remitting (RRMS) — clear attacks with recovery — 85% at onset. Secondary progressive — gradual worsening after years of relapses. Primary progressive (PPMS) — steady decline from start without distinct relapses — harder to treat, ocrelizumab approved. Does MS affect life expectancy? Slightly reduced on average — gap narrowing with modern DMTs — most live near-normal lifespan. Complications — mobility impairment, infections. Quality of life highly variable — many remain working with support and treatment.

## Sources

- [NHS — Multiple sclerosis](https://www.nhs.uk/conditions/multiple-sclerosis/)
- [NICE — MS management](https://www.nice.org.uk/guidance/ta527)
- [MS Society](https://www.mssociety.org.uk/)